EDQM Publications. Mrs Caroline Larsen Le Tarnec Head Public Relations & Documentation Division

Size: px
Start display at page:

Download "EDQM Publications. Mrs Caroline Larsen Le Tarnec Head Public Relations & Documentation Division"

Transcription

1 EDQM Publications Mrs Caroline Larsen Le Tarnec Head Public Relations & Documentation Division C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 1

2 The EuropeanPharmacopoeia SIXTH EDITION: 3 Suppl/year Publication status: Last supplement 6.8 released in December 09 Implemented in July 2010 Non-cumulative Change bars indicate changes to previous version. C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 2

3 General organisation: volume 1 Introduction General Notices General Texts General Monographs Dosage forms Vaccines Immunosera Radiopharm. Sutures Homoeopathy C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 3

4 General organisation: volume 2 Other specific monographs Index C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 4

5 6th Edition Supplement Publication Schedule Implementation Date /06/ /01/ /10/ /04/ /01/ /07/ /06/ /01/ (+reagents) 01/10/ /04/ /01/ /07/ /06/ /01/ (+reagents) 01/10/ /04/ /01/ /07/ /06/ /01/2011 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 5

6 European Pharmacopoeia Electronic versions ~ same price, same publication programme cumulative available for standalone computers (since 6.6 on DVD) since supplement 6.6: a new publication software (with functionality of the online version) is also on the DVD (7 th edition: only new software will be available!) available online (internet) new: monthly updated Spanish version (~200 texts/month) new: archive version for current subscribers licence model: 1 licence = 1 simultaneous user, maximum 2 computers H-J. Bigalke, 08/12/ EDQM, Council of Europe, All rights reserved

7 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 7

8 Archive Version C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 8

9 Spanish Version C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 9

10 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 10

11 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 11

12 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 12

13 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 13

14 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 14

15 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 15

16 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 16

17 The European Pharmacopoeia 7 th Edition SEVENTH EDITION: 3 Suppl/year Publication (about): July, September, December Implemented in July, January, April Non-cumulative Change bars indicate changes to previous version. C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 17

18 What has changed since the 6th Ed.? A short selection of the most interesting topics: New Chapter 5.15: Functionality-related characteristics of excipients; Revision of the chapters: Pesticide residues : Microbiological examination of non-sterile products: microbial enumeration tests : Microbiological examination of non-sterile products: test for specified micro-organisms C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 18.

19 What has changed since the 6th Ed? : Chromatographic separation techniques : Determination of ochratoxin A in herbal drugs : Microbiological quality of non-sterile pharmaceutical preparation and substances for pharmaceutical use C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 19

20 What has changed since the 6th Ed? NEW Indication of the status of pharmacopoeial harmonization between EP, USP and JP In a chapter 5.8 : Pharmacopoeial harmonization of the following chapters Electrophoresis (2.2.31); Capillary electrophoresis (2.2.47); Isoelectric focusing (2.2.54); Peptide mapping (2.2.55); Amino acid analysis (2.2.56); Friability of uncoated tablets (2.9.7); Specific surface area by gas adsorption (2.9.26); Powder flow (2.9.36); Optical microscopy (2.9.37); Particle-size distribution estimation by analytical sieving (2.9.38) C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 20

21 What has changed since the 6th Ed? New important monographs: Valsartan; Ziprasidone hydrochloride monohydrate; Teicoplanin; Telmisartan; Tiotropium bromide; Saquinavir mesilate; Sevoflurane; Pantoprazole sod. Sesquihydrate; Pramipexole dihydrochloride monohydrate; Raloxifene hydrochloride; Levetiracetam; Meropenem; Irbesartan; Fluvastatin sodium ; Adapalene; Docetaxel trihydrate; Entacapone; Epinastine hydrochloride C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 21

22 Pharmeuropa Published quarterly A NEW EDITORIAL LINE Draft monographs for comment News and general information Readers tribune C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 22

23 Pharmeuropa Bio & Scientific Notes Results of collaborative trials on the establishment of biological reference substances Scientific articles related to the European Pharmacopoeia Searchable on scientific search engines (PubMed in NLM) Published twice a year C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 23

24 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 24

25 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 25

26 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 26

27 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 27

28 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 28

29 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 29

30 Standard Terms A glossary in 31 languages of: pharmaceutical dosage forms routes of administration containers C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 30

31 Standard Terms Very useful for: MA dossiers Leaflets Labels C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 31

32 Standard Terms Online Address: Based on Unicode character encoding, available only on the most recent computer operating systems No printed version available any more C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 32

33 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 33

34 Blood components 14th Edition (2008) Guidelines and principles for the preparation, use and quality assurance of blood components Contains measures designed to ensure the safety, efficacy and quality of blood components Particularly intended for all those working in blood transfusion services C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 34

35 Organ transplantation Guide to safety and quality assurance for the transplantation of organs, tissues and cells - 3rd edition (2007) Currently published by the Council of Europe, in the future to be published by the EDQM Guidance to maximise the quality of organs, tissues and cells, and thereby the success rate of transplants, and to minimise risks Includes safety and quality assurance standards for the procurement, preservation, processing and distribution of organs, tissues and cells of human origin (allogenic and autologous) used for transplantation purposes C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 35

36 NEW Pharmaceutical Care: report on the current awareness and understanding of pharmaceutical care approaches for quality assessment implementation of pharmaceutical care in practice required competences and skills conclusions of 58 replies from 17 countries C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 36

37 Technical guides Technical guides for: the elaboration of monographs the elaboration of monographs on synthetic peptides and recombinant DNA proteins structure & nomenclature of chemical formulae herbal drugs and herbal drug preparations fatty oils and derivatives vaccines and other immunological human medicinal products European Pharmacopoeia Style Guide Free to download: Products & Services C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 37

38 Combistats A statistical software specifically designed to use together with general chapter 5.3 Statistical analysis of results Published directly by the EDQM C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 38

39 C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 39

40 Combistats For more information about the software please contact: Website: where a free demo version can be downloaded C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 40

41 Checking the authenticity Users of the Pharmacopoeia are advised to register their copy, using our website: Register with the unique ID (EPID) number shown on the label This registration is required for Users of the electronic versions (password/activation) Accessing our helpdesk C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 41

42 Checking the authenticity - 1. Colourful areas 2. Mirrored minitext 3. Colourful letters/stars 4. Lens effect the hologram - C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 42

43 Q: I am only interested in one monograph. Can I just get a copy of that? A: No FAQ on publications Why? The specific monographs contain a number of cross references to other parts of the publication (general monographs, general methods ), so a monograph is never self-sufficient. C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 43

44 Questions? EDQM Helpdesk: Select the right thematic and ask your question 90 EDQM staff in back office to answer all questions received The only channel to use to contact EDQM for technical, scientific and commercial matters C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 44

45 Distributors in India (1) UNITED BOOKS AND PERIODICALS 7, Vishwadham, Prabhat Clny. Rd. n 9 Santacruz (East) MUMBAI TEL: or FAX: CONTACT: Rahul M. Gavankar, unitedbooks@mtnl.net.in or unitedbooks@gmail.com EDUCATIONAL BOOK CENTRE 33, Bhagwan Bhuvan, 196 Samuel Street MUMBAI TEL: ; FAX: CONTACT: Mukesh H. Doshi, ebc@vsnl.net C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 45

46 Distributors in India (2) M/s SHAH BOOK HOUSE PVT LTD Devka Mahal, Opp Central Bank, Bank Street Koti, HYDERABAD TEL: ; FAX: CONTACT: Anil Shah, KAMAL UDYOG F-4, 1st Floor, Velho Trade Centre Gen. B. Guesdes Road, Next to Goa Sahakar Bhandar Panaji, GOA TEL: ; FAX: C. Larsen Le Tarnec, 29/01/ EDQM, Council of Europe, All rights reserved 46

The International Pharmacopoeia Overview

The International Pharmacopoeia Overview The International Pharmacopoeia Overview Prepared by Caroline Mendy Technical Officer - Quality Assurance and Safety: Medicines The International Pharmacopoeia P Content & Scope WHO Expert Committee on

More information

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective 1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation

More information

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, 2015 Dr. Helmut Rockstroh Overview Introduction - Scope Pharmacopoeial + HA Positions Examples / Case Studies Discussion 2 Introduction:

More information

OMCL Network of the Council of Europe GENERAL DOCUMENT

OMCL Network of the Council of Europe GENERAL DOCUMENT OMCL Network of the Council of Europe GENERAL DOCUMENT PA/PH/OMCL (09) 87 4R OMCL Network support for the implementation of the CoE MEDICRIME Convention Full document title and reference How the OMCL Network

More information

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution

More information

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com

More information

Submission of comments on Review of the Variations Guidelines (EC 1234/2008)

Submission of comments on Review of the Variations Guidelines (EC 1234/2008) 12 July 2012 Submission of comments on Review of the Variations Guidelines (EC 1234/2008) Comments from: Name of organisation or individual Leem Please note that these comments and the identity of the

More information

Nelufar Mohajeri Director, Member and Professional Relations

Nelufar Mohajeri Director, Member and Professional Relations Dear Delegates, Observer Representatives and Meeting Attendees: We were so pleased to see so many of you at the 2015 USP Convention Meeting this past week in Washington, DC. Here are some highlights of

More information

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Dr. Øyvind Holte Norwegian Medicines Agency EMA PAT team/ EDQM PAT working party 15 October, 2014, Heidelberg

More information

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality EDQM Conference Quality of Medicines in a Globalised World: Dreams and Reality 14-15 October 2010 Prague, Czech Republic 2010 EDQM, Council of Europe, All rights reserved Dr Georges France Ms Suzette Kox

More information

PDA 71 Years of Connecting People, Science and Regulation

PDA 71 Years of Connecting People, Science and Regulation PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International

More information

2008 Course Programs Schedule

2008 Course Programs Schedule 2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)

More information

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective 14 th DIA Japan Annual Meeting 2017 November 12-14, 2017 Tokyo Big Sight Ariake ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective Yasuhiro Kishioka, Ph.D. Principal Reviewer Office

More information

QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS

QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS VICH GL 45 (QUALITY) BRACKETING AND MATRIXING April 2010 For Implementation at Step 7 QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS

More information

The Monographs A Comprehensive Manual On All You Need To Know To Become An Expert Deductionist

The Monographs A Comprehensive Manual On All You Need To Know To Become An Expert Deductionist The Monographs A Comprehensive Manual On All You Need To Know To Become An Expert Deductionist We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks

More information

Important information on the further use of passivating agents with Cr(VI) content

Important information on the further use of passivating agents with Cr(VI) content Important information on the further use of passivating agents with Cr(VI) content The approval procedure for chromium trioxide (CrO 3 ) and the ensuing acids (including oligomers) in accordance with EC

More information

NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM

NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM Document No.GLP-102 Version/Issue No. 3 Issue Date: October, 2007 NATIONAL GLP COMPLIANCE MONITORING AUTHORITY DEPARTMENT

More information

the SPD company Dr Clive Simon, Principal, The SPD Company.

the SPD company Dr Clive Simon, Principal, The SPD Company. the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated

More information

Issues in Emerging Health Technologies Bulletin Process

Issues in Emerging Health Technologies Bulletin Process Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The

More information

WHO Regulatory Systems Strengthening Program

WHO Regulatory Systems Strengthening Program WHO Regulatory Systems Strengthening Program MVP RHT RSS CRS www.who.int Minimal capacity met Eligibility for vaccine PQ WHO listed NRAs WHO NRA 5 step capacity building Development of NRA benchmarking

More information

Challenges of Implementation of ICH Q 8

Challenges of Implementation of ICH Q 8 Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated

More information

Q8 and Q8 annex An industry Perspective

Q8 and Q8 annex An industry Perspective Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference

More information

Overview of USP s Research and Innovation Activities. Michael Ambrose Ph.D. Director, Research and Innovation

Overview of USP s Research and Innovation Activities. Michael Ambrose Ph.D. Director, Research and Innovation Overview of USP s Research and Innovation Activities Michael Ambrose Ph.D. Director, Research and Innovation USP is committed to Tailoring programs to address stakeholder priorities Fostering next generation

More information

United Nations Statistics Division Programme in Support of the 2020 Round of Population and Housing Censuses

United Nations Statistics Division Programme in Support of the 2020 Round of Population and Housing Censuses United Nations Statistics Division Programme in Support of the 2020 Round of Population and Housing Censuses Session 2 Srdjan Mrkić United Nations Statistics Division Resolution UN Statistical Commission

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

SYNONYMS: Bee wax, Cera alba, White Wax, Wax, Cera flava, Yellow Wax

SYNONYMS: Bee wax, Cera alba, White Wax, Wax, Cera flava, Yellow Wax Beeswax SYNONYMS: Bee wax, Cera alba, White Wax, Wax, Cera flava, Yellow Wax INTRODUCTION: Beeswax is a 100 % natural wax produced in the bee hive of honey bees of the genus Apis. It is mainly esters of

More information

New Draft Manual Of Patent Practice And Procedure - Patent Office India (2008) >>>CLICK HERE<<<

New Draft Manual Of Patent Practice And Procedure - Patent Office India (2008) >>>CLICK HERE<<< New Draft Manual Of Patent Practice And Procedure - Patent Office India (2008) This (Manual of Patent Practice and Procedure by the Indian Patent Office) patent office in India is divided into four offices:

More information

Feedback EMEA / Industry Discussion

Feedback EMEA / Industry Discussion Feedback EMEA / Industry Discussion Eli Lilly & Co Ltd Case Study: Use of In-Line Near-Infrared Spectroscopy to Monitor Segregation of a Pharmaceutical Powder Blend in a Tablet Press Martin Diller PhD,

More information

QUALITY REQUIREMENTS FOR ARTEMISININ AS A STARTING MATERIAL IN THE PRODUCTION OF ANTIMALARIAL ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

QUALITY REQUIREMENTS FOR ARTEMISININ AS A STARTING MATERIAL IN THE PRODUCTION OF ANTIMALARIAL ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) August 2010 RESTRICTED QUALITY REQUIREMENTS FOR ARTEMISININ AS A STARTING MATERIAL IN THE PRODUCTION OF ANTIMALARIAL ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) Please address comments on this proposal, by

More information

ENFSI European Fingerprint Working Group. Best Practice Manual for Fingerprint Examination

ENFSI European Fingerprint Working Group. Best Practice Manual for Fingerprint Examination 2012 ENFSI Monopoly Grant Application to the EC B6 ENFSI European Fingerprint Working Group Best Practice Manual for Fingerprint Examination Maj. Aldo Mattei, PhD RIS Carabinieri, Italy Outline 1 Framework:

More information

QUALITY REQUIREMENTS FOR ARTEMISININ AS A STARTING MATERIAL IN THE PRODUCTION OF ANTIMALARIAL ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

QUALITY REQUIREMENTS FOR ARTEMISININ AS A STARTING MATERIAL IN THE PRODUCTION OF ANTIMALARIAL ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) August 2011 RESTRICTED 1 2 3 4 5 6 7 8 9 QUALITY REQUIREMENTS FR ARTEMISININ AS A STARTING MATERIAL IN TE PRDUCTIN F ANTIMALARIAL ACTIVE PARMACEUTICAL INGREDIENTS (APIs) REVISED DRAFT FR CMMENT 10 11 12

More information

Turning knowledge into success. SCHOTT FIOLAX Academy

Turning knowledge into success. SCHOTT FIOLAX Academy Turning knowledge into success. SCHOTT FIOLAX Academy 2 SCHOTT is an international technology group with 130 years of experience in the areas of specialty glasses and materials and advanced technologies.

More information

Swissmedic, Swiss Agency for Therapeutic Products

Swissmedic, Swiss Agency for Therapeutic Products PMDA International Forum, 8 February 2014 Swissmedic, Swiss Agency for Therapeutic Products Jürg H. Schnetzer, Executive Director Grüezi. Bonjour. Buongiorno. Allegra. 2 Overview Swissmedic Introduction

More information

H e l p I n g H e a l t h c a r e C a r e. U.S. Drug Supply Chain Security Act (DSCSA) Product Specifications Overview

H e l p I n g H e a l t h c a r e C a r e. U.S. Drug Supply Chain Security Act (DSCSA) Product Specifications Overview U.S. Drug Supply Chain Security Act (DSCSA) Product Specifications Overview Agenda Systems, Notification and Disposition What is a Suspect Product? What is an Illegitimate Product? Investigations Product

More information

JUST SCRATCHING THE SERVICE

JUST SCRATCHING THE SERVICE CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5

More information

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team

More information

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality

EDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality EDQM Conference Quality of Medicines in a Globalised World: Dreams and Reality 14-15 October 2010 Prague, Czech Republic 2010 EDQM, Council of Europe, All rights reserved Plenary Session Dr Moheb M. Nasr

More information

KEY HIGHLIGHTS WORKSHOP 2019

KEY HIGHLIGHTS WORKSHOP 2019 KEY HIGHLIGHTS aenvironmental Monitoring afacility Design apractical Case Studies avisual Inspection aclean Room Behaviours aprocess Simulations arecent 483s, warning Letters and EU Observations WORKSHOP

More information

Open science and research DATA POLICY OF THE UNIVERSITY OF TURKU

Open science and research DATA POLICY OF THE UNIVERSITY OF TURKU Open science and research DATA POLICY OF THE UNIVERSITY OF TURKU 2016 1 INTRODUCTION Decision of the Rector 9 February 2016 The data policy of the University of Turku describes the University level principles

More information

PMDA perspective on Quality by Design for pharmaceutical products

PMDA perspective on Quality by Design for pharmaceutical products PMDA perspective on Quality by Design for pharmaceutical products Junichi Fukuchi, Ph.D. Office of Cellular and Tissue-based Products Pharmaceuticals and Medical Devices Agency (PMDA) Annual conference

More information

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY FUNDAMENTALS OF GLOBAL LAW, PRACTICE AND STRATEGY by PHILIP W. GRUBB European Patent Attorney CLARENDON PRESS OXFORD 1999 CONTENTS Preface to the

More information

Terrence Tougas. Dennis Sandell

Terrence Tougas. Dennis Sandell Terrence Tougas Boehringer Ingeheim, Ridgefield, CT Dennis Sandell S5 Consulting, Lund, Sweden (c) 2011 Sandell & Tougas 1 Transforming the general concept of Quality into objective, well defined and actionable

More information

ICH Q-IWG Integrated Training Programme

ICH Q-IWG Integrated Training Programme Implementation of ICH Q8, Q9, Q10 ICH Q-IWG Integrated Training Programme International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer

More information

Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, LONAVALA

Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, LONAVALA COMBATING COUNTERFEIT DRUGS WITH PACKAGING TECHNOLOGY Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, 2009 -LONAVALA Content Counterfeit Medicines:

More information

COUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices

COUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices THE COUNCIL OF THE EUROPEAN communities, Having regard to the Treaty establishing the European Economic Community, and in particular

More information

Office of Pharmaceutical Quality Key Quality Initiatives

Office of Pharmaceutical Quality Key Quality Initiatives Office of Pharmaceutical Quality Key Quality Initiatives Ashley B. Boam, MSBE Director Office of Policy for Pharmaceutical Quality Office of Pharmaceutical Quality Center for Drug Evaluation and Research

More information

Andalusian Agency for Health Technology Assessment (AETSA)

Andalusian Agency for Health Technology Assessment (AETSA) Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction

More information

ICH Q8 / ICH Q11 Training Course

ICH Q8 / ICH Q11 Training Course ICH Q8 / ICH Q11 Training Course From QbD to Process Validation Speakers: Dr Thomas Hille LTS Lohmann Therapie- Systeme AG Dr Øyvind Holte Norwegian Medicines Agency, EDQM PAT working party/ EMA PAT team

More information

Quality by Design and OINDP. Today s Presentation

Quality by Design and OINDP. Today s Presentation Quality by Design and OINDP Setting the Stage John C Berridge IPAC-RS September 2008 Today s Presentation QbD definition Setting the stage from an ICH perspective Future Opportunities 2 QbD Definition

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003 Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared

More information

Section heading. Strapline sub-heading

Section heading. Strapline sub-heading Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide

More information

Fact Sheet IP specificities in research for the benefit of SMEs

Fact Sheet IP specificities in research for the benefit of SMEs European IPR Helpdesk Fact Sheet IP specificities in research for the benefit of SMEs June 2015 1 Introduction... 1 1. Actions for the benefit of SMEs... 2 1.1 Research for SMEs... 2 1.2 Research for SME-Associations...

More information

Croma Enterprise Cromtech India

Croma Enterprise Cromtech India UV 1601 - Split Beam & Dual (equivalent to Double beam Spectro Photometer ) Wide wavelength range, satisfying requirements of various fields. The split-beam ratio monitoring system provides accurate measurements

More information

BETTER YOUR PRODUCTIVITY WITH OUR ALL-PURPOSE WORKFORCE SCANNERS.

BETTER YOUR PRODUCTIVITY WITH OUR ALL-PURPOSE WORKFORCE SCANNERS. SCANNERS BETTER YOUR PRODUCTIVITY WITH OUR ALL-PURPOSE WORKFORCE SCANNERS. Focus on work that matters with the high-speed and all-purpose Epson WorkForce DS-530 scanners. Designed to fragile paper documents

More information

Marine operations and marine warranty

Marine operations and marine warranty STANDARD DNVGL-ST-N001 Edition June 2016 Amended November 2016 Full version For full version, enter My DNV GL (https://my.dnvgl.com/), click "Add services" and find "DNV GL Noble Denton marine services

More information

DWK Life Sciences DURAN GL 45 Bromobutyl Rubber Stopper: FAQs

DWK Life Sciences DURAN GL 45 Bromobutyl Rubber Stopper: FAQs DWK Life Sciences DURAN GL 45 Bromobutyl Rubber Stopper: FAQs DURAN GL 45 Bromobutyl Rubber Stopper Stopper and material properties optimised to fit DURAN GL 45 bottles Low permeability to air, gases and

More information

QbD Application in Japan: PMDA Perspective

QbD Application in Japan: PMDA Perspective CMC Strategy Forum Japan 2013 Hotel Okura, Tokyo, Japan, December 9 10, 2013 QbD Application in Japan: PMDA Perspective Yasuhiro Kishioka, PhD. Reviewer Office of Cellular and Tissue based Products Pharmaceuticals

More information

WANT TO PARTICIPATE IN RESEARCH? THERE S AN APP FOR THAT!

WANT TO PARTICIPATE IN RESEARCH? THERE S AN APP FOR THAT! WANT TO PARTICIPATE IN RESEARCH? THERE S AN APP FOR THAT! SECURITY AND PRIVACY ISSUES WITH THE INCREASED USE OF CONNECTED DEVICES, APPS, AND SOCIAL MEDIA IN RESEARCH. PRESENTED BY: DAVID MATA, SENIOR ASSOCIATE,

More information

28 March Report of the Working Group on Pharmaceuticals and Public Health of the High Level Committee on Health.

28 March Report of the Working Group on Pharmaceuticals and Public Health of the High Level Committee on Health. PHARMACEUTICALS AND PUBLIC HEALTH IN THE EU: PROPOSALS TO THE HIGH LEVEL COMMITTEE ON HEALTH FOR POLICIES AND ACTIONS IN THE FRAMEWORK OF THE TREATY OF AMSTERDAM a) 28 March 2000 a) Report of the Working

More information

Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use

Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Document issued on: November 30, 2004 The draft of this document

More information

Pramod Kumar Naik Senior Application Engineer MathWorks Products

Pramod Kumar Naik Senior Application Engineer MathWorks Products MATLAB & SIMULINK Pramod Kumar Naik Senior Application Engineer MathWorks Products 2 Enabling Excellence Through Innovation System Engineering Intellectual Property (IP) EDA & Semiconductor University

More information

PATENT ATTORNEYS TRADE MARK ATTORNEYS

PATENT ATTORNEYS TRADE MARK ATTORNEYS PATENT ATTORNEYS TRADE MARK ATTORNEYS 02 INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need

More information

CURRICULUM VITAE. Environment, Occupational Health and Safety)

CURRICULUM VITAE. Environment, Occupational Health and Safety) CURRICULUM VITAE PERSONAL INFORMATION Name DIMITRIU LAVINIA CRISTINA Nationality Romanian Date of birth 13 August 1957 Sex Employer / Field of activity WORK EXPERIENCE female Antibiotice Quality Unit 25

More information

COUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices

COUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices THE COUNCIL OF THE EUROPEAN communities, Having regard to the Treaty establishing the European Economic Community, and in particular

More information

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) MFDS Nov 11, 2016 1 Agenda Introduction of PMDA ICH Q12 QbD assessment

More information

SEMESTER-I SEMESTER-II

SEMESTER-I SEMESTER-II SEMESTER-I SEMESTER-II Basic Sciences Courses General Chemistry Fundamental Mathematics for Biologists Applied Physics-i for Life Science Understanding Self for Effectiveness English Language Usage Essentials

More information

BULLETIN # 97. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 1, 2018

BULLETIN # 97. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 1, 2018 BULLETIN # 97 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 1, 2018 The amended Drug Interchangeability Formulary Regulation will

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring PDA Europe Training Course The Parenteral Drug Association presents: Mastering Environmental Monitoring 4-5 September 2018 Wattwil Switzerland Training & Education Program europe.pda.org PDA Education

More information

STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN

STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN CHRISTOPHER J POTTER ISPE ADVISOR AND CMC CONSULTANT 1 AGENDA Background ICH Guidelines Terms and Definitions Supporting Information ISPE publications

More information

SEMESTER-I SEMESTER-II

SEMESTER-I SEMESTER-II SEMESTER-I SEMESTER-II Basic Sciences Courses General Chemistry Fundamental Mathematics for Biologists Applied Physics-i for Life Science Understanding Self for Effectiveness English Language Usage Essentials

More information

Global Trends in Physics Publishing Background and Developments

Global Trends in Physics Publishing Background and Developments Global Trends in Physics Publishing Background and Developments Presented by: Steve Watson, Executive Publisher Surfaces and Interfaces Date: 15 September 2009 Presentation created by James Milne 2007

More information

United Nations Environment Programme

United Nations Environment Programme UNITED NATIONS MC UNEP/MC/COP.1/11 Distr.: General 23 May 2017 Original: English United Nations Environment Programme Conference of the Parties to the Minamata Convention on Mercury First meeting Geneva,

More information

Value Paper. Are you PAT and QbD Ready? Get up to speed

Value Paper. Are you PAT and QbD Ready? Get up to speed Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more

More information

The basics of successful IP-Management in Horizon 2020

The basics of successful IP-Management in Horizon 2020 The basics of successful IP-Management in Horizon 2020 Jörg Scherer CEO Eurice GmbH Prague 11/05/2017 Roadmap Setting the scene The Framework Our service offer Speaker profile: Jörg Scherer Managing Director

More information

ENCePP Work Plan

ENCePP Work Plan EMA/231507/2012 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP

More information

Economic and Social Council

Economic and Social Council United Nations Economic and Social Council ECE/CES/ GE.41/2012/8 Distr.: General 14 March 2012 Original: English Economic Commission for Europe Conference of European Statisticians Group of Experts on

More information

Pharmaceutical Process Development

Pharmaceutical Process Development Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage

More information

Foreign Particulate Matter testing using the Morphologi G3

Foreign Particulate Matter testing using the Morphologi G3 Foreign Particulate Matter testing using the Morphologi G3 Introduction The Morphologi G3 with its Foreign Particle Detection capabilities allows the detection, enumeration and size classification of foreign

More information

APPLICATIONS. NEW GENERATION Tissue homogenizer SAMPLE PREPARATION & CELL LYSIS.

APPLICATIONS. NEW GENERATION Tissue homogenizer SAMPLE PREPARATION & CELL LYSIS. APPLICATIONS DISTRIBUTOR R&D Biotechnology Molecular biology and proteomic Genotype determination Pharmacology and Toxicology Toxic analysis, Metabolism studies Forensic Medicine DNA/RNA tests, Drugs and

More information

DRAFT TANZANIA STANDARD. TBS/CDC-2(4970) P3- Carbolic Soap - Specification (Revision of TZS 221:1984)

DRAFT TANZANIA STANDARD. TBS/CDC-2(4970) P3- Carbolic Soap - Specification (Revision of TZS 221:1984) DRAFT TANZANIA STANDARD TBS/CDC-2(4970) P3- Carbolic Soap - Specification (Revision of TZS 221:1984) TANZANIA BUREAU OF STANDARDS Foreword This Draft Tanzania Standard is being developed by the Soap and

More information

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Title: Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Author:

More information

ENGINEERING COUNCIL. GUIDANCE ON SUSTAINABILITY for the Engineering Profession.

ENGINEERING COUNCIL. GUIDANCE ON SUSTAINABILITY for the Engineering Profession. ENGINEERING COUNCIL GUIDANCE ON SUSTAINABILITY for the Engineering Profession www.engc.org.uk/sustainability This guidance describes the role of professional engineers in sustainability. It lists six principles

More information

6th International Conference on. Biological Sciences. November 12-14, 2018 New Delhi, India

6th International Conference on. Biological Sciences. November 12-14, 2018 New Delhi, India 6th International Conference on Biological Sciences November 12-14, 2018 New Delhi, India ATTENDEES Dear Attendees, We are glad to announce the 6th International Conference on Biological Sciences with

More information

REACH 2018 and after. CLEPA Materials Regulations Event. 19 April Monique Pillet Scientific Officer

REACH 2018 and after. CLEPA Materials Regulations Event. 19 April Monique Pillet Scientific Officer REACH 2018 and after CLEPA Materials Regulations Event 19 April 2018 Monique Pillet Scientific Officer Overview REACH 2018 Communication in supply chain Substances in articles 2 What do we expect? Many

More information

Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ

Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ Ultrasensitive LC MS/MS: Agilent 6470 and 6495 LC-QQQ ROCK SOLID Performance for Trace-Level Quantitation Agilent Technologies 1 Brief History of Agilent 6400 QQQ LC/MS 6410 2006 6460 Agilent Jet Stream

More information

Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4

Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4 Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4 Paul Brooks SVP Healthcare Solutions Representing BSI Notified Body EU Medical

More information

PATENT ATTORNEYS TRADE MARK ATTORNEYS

PATENT ATTORNEYS TRADE MARK ATTORNEYS PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need

More information

BASIC SCIENCES CENTER BIOCHEMICAL ENGINEER

BASIC SCIENCES CENTER BIOCHEMICAL ENGINEER OBJECTIVE Train professionals with creativity, critical and humanistic thinking to develop, implement and optimize processes, products and services involving the rational and comprehensive utilization

More information

Advisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing

Advisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing (1) Virginia G. Beakes-Read Genentech, USA Ginny works for Genentech, Inc., as the Director, Regulatory Policy Liaison, for the Strategic Operations Office in Washington, D.C. She works on a variety of

More information

ENCePP Work Plan

ENCePP Work Plan EMA/150117/2014 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP

More information

Contents. About Grupo Plimon Global Presence Worldwide Locations Business Units Production Site / R&D Quality Guarantee Fair Trade & CSR

Contents. About Grupo Plimon Global Presence Worldwide Locations Business Units Production Site / R&D Quality Guarantee Fair Trade & CSR Grupo Plimon Contents About Grupo Plimon Global Presence Worldwide Locations Business Units Production Site / R&D Quality Guarantee Fair Trade & CSR About Grupo Plimon Grupo Plimon, was established in

More information

The Process Analytical Technology Initiative: PAT and the Pharmacopeias

The Process Analytical Technology Initiative: PAT and the Pharmacopeias The Process Analytical Technology Initiative: PAT and the Pharmacopeias Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science CDER, FDA EDQM Spring Conference, Cannes, 3-43 4 May 2004

More information

Quantum Design Japan. Introducing Advanced Technology to Japan

Quantum Design Japan. Introducing Advanced Technology to Japan Introducing Advanced Technology to Japan Profile Incorp. date: July 1, 1997 Ownership: Business: Offices: Employees: Revenue: < $25M Address: Subsidiary of Quantum Design www.qdusa.com Sales and service

More information

T:GENIUS GEL IMAGING AT A TOUCH

T:GENIUS GEL IMAGING AT A TOUCH T:GENIUS GEL IMAGING AT A TOUCH The T:Genius is an integrated system for DNA and protein analysis and gel documentation. Based on the successful Syngene gel documentation range, the T:Genius features an

More information

2016 Media Pack.

2016 Media Pack. 2016 Media Pack ABOUT MEPCA MEPCA is a monthly magazine not only for engineers, production management and decision-makers in manufacturing and processing but is also aimed at professionals working in the

More information

SUTURA Nonabsorbable surgical suture U.S.P Black Braided Silk.

SUTURA Nonabsorbable surgical suture U.S.P Black Braided Silk. Instructions for use DESCRIPTION: SUTURA Nonabsorbable surgical suture U.S.P Black Braided Silk. Silk suture is a nonabsorbable sterile surgical suture composed of an organic protein called fibroin. This

More information

TEST 1 SYSTEMS ANALYSIS CHAPTERS 4

TEST 1 SYSTEMS ANALYSIS CHAPTERS 4 page 1 / 5 page 2 / 5 test 1 systems analysis pdf Damage Analysis & Estimating Certification Test (B6) Objective: To identify and recognize those Estimators who possess knowledge of the skills necessary

More information

Fire Service College - immersive 3D emergency training

Fire Service College - immersive 3D emergency training Fire Service College - immersive 3D emergency training The Fire Service College are an award-winning leader in fire and emergency response training and operate one of the world s largest fire and rescue

More information